Ethanol and the tobacco-specific carcinogen, NNK, contribute to signaling in immortalized human pancreatic duct epithelial cells

Pancreas

Volumn 33, Issue 1, 2006, Pages 53-62

  Askari, Minoo D F ^a   Tsao, Ming Sound ^b   Cekanova, Maria ^a   Schuller, Hildegard M ^a,c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Cyclic AMP; Ethanol; MAPK; NNK; Pancreatic cancer; PKA

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ADENYLATE CYCLASE; ALCOHOL; CARCINOGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMOBILIZED CELL; PANCREAS CANCER; PANCREAS DUCT; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; SMOKING; TOBACCO; WESTERN BLOTTING;

CARCINOGENS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; CREB-BINDING PROTEIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; ETHANOL; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITROSAMINES; PANCREATIC DUCTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 33745684935     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000226883.55828.e9     Document Type: Article

References (70)

1. Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review, 1973-1996. Bethesda, MD: National Cancer Institute; 1999.
2. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
3. Wynder EL, Mabuchi K, Maruchi N, et al. Epidemiology of cancer of the pancreas. J Natl Cancer Inst. 1973;50:645-667.
4. Alcohol and Health, Tenth Special Report to the US Congress on Alcohol and Health. DHSS, PHS-NIAAA Publication. 2000.
5. Lin RS, Kessler II. A multifactorial model for pancreatic cancer in men. Epidemiologic evidence. JAMA. 1981;245:147-152.
6. Hecht SS. Recent studies on the mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit Rev Toxicol. 1996;26:163-181.
7. Belinsky A, Devereux TR, Maronpot RR. The relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res. 1989;40:5305-5311.
8. Sakorafas GH, Tsiotou AG, Tsitos GG. Molecular biology of pancreatic cancer; oncogenes, tumor suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev. 2000;26:29-52.
9. Schuller HM, Jorquera R, Reichert A, et al. Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 1993;53:2498-2501.
10. Schuller HM, Zhang L, Weddle DL, et al. The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol. 2002;128:525-532.
11. Ikematsu Y, Liu G, Fienhold MA, et al. In vitro pancreatic ductal cell carcinogenesis. Int J Cancer. 1997;72:1095-1103.
12. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol. 2004;39:155-165.
13. Obe G, Ristow H. Mutagenic, carcinogenic and teratogenic effects of alcohol. Mutat Res. 1979;65:229-259.
14. Brooks PJ. DNA damage, DNA repair, and alcohol toxicity: a review. Alcohol Clin Exp Res. 1997;21:1073-1082.
15. Singh NP, Khan A. Acetaldehyde: genotoxicity and cytotoxicity in human lymphocytes. Mutat Res. 1995;337:9-17.
16. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis. 2005;9:151-169.
17. Hsu TC. Alcohol: a cocarcinogen in head and neck malignancies. Adv Exp Med Biol. 1992;320:35-37.
18. Schuller HM, Tithof PK, Williams M, et al. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via β-adrenergic receptor-mediated release of arachidonic acid. Cancer Res. 1999;59:4510-4515.
19. Weddle DL, Tithoff P, Williams M, et al. Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis. 2000;122:473-479.
20. Askari M, Tsao MS, Schuller HM. The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized normal human pancreatic duct epithelia through β-adrenergic transactivation of EGF receptors. Cancer Res Clin Oncol. 2005;131:639-648.
21. Novak I. Beta-adrenergic regulation of ion transport in pancreatic ducts: patch-clamp study of isolated rat pancreatic ducts. Gastroenterology. 1998;115:714-721.
22. Mailliard WS, Diamond I. Recent advances in the neurobiology of alcoholism: the role of adenosine. Pharmacol Ther. 2004;101:39-46.
23. Ouyang H, Mou Lj, Luk C, et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol. 2000;157:1623-1631.
24. Pandey SC. The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction. Pharmacol Ther. 2004;104:47-58.
25. Dohrman DP, Diamond I, Gordon AS. Proc Natl Acad Sci USA. 1996;93:10217-10221.
26. Sassone-Corsi P. Transcription factors responsive to cAMP. Annu Rev Cell Dev Biol. 1995;11:355-377.
27. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem. 1997;66:807-822.
28. Constantinescu A, Diamond I, Gordon AS. Ethanol-induced translocation of cAMP-dependent protein kinase to the nucleus. Mechanism and functional consequences. J Biol Chem. 1999;274:26985-26991.
29. Schuller HM, Jorquera R, Lu X, et al. Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters. J Cancer Res Clin Oncol. 1994;120:200-203.
30. Jorquera R, Castonguay A, Schuller HM. Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes. Drug Metab Dispos. 1992;20:510-517.
31. Hilberg FA, Aguzzi A, Howells N, et al. c-Jun is essential for normal mouse development and hepatogenesis. Nature. 1993;365:179-181.
32. Hoek JB, Thomas AP, Rooney TA, et al. Ethanol and signal transduction in the liver. FASEB J. 1992;6:2386-2396.
33. Miyakawa T, Yagi T, Kitazawa H, et al. Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. Science. 1997;278:698-701.
34. Resnicoff M, Sell C, Ambrose D, et al. Ethanol inhibits the autophosphorylation of the insulin-like growth factor 1 (IGF-1) receptor and IGF-1-mediated proliferation of 3T3 cells. J Biol Chem. 1993;268:21777-21782.
35. Lee YJ, Lee JH, Han HJ. Ethanol-inhibited [3H]thymidine incorporation via protein kinase C-p44/42 mitogen-activated protein kinase/phospholipase A2 signal pathway in renal proximal tubule cells. Alcohol Clin Exp Res. 2004;28:1172-1179.
36. Thurston AW, Shukla SD. Ethanol modulates epidermal growth factor-stimulated tyrosine kinase and phosphorylation of PLC-gamma 1. Biochem Biophys Res Commun. 1992;185:1062-1068.
37. Pandey SC. Protein kinase C: molecular and cellular targets for the action of ethanol. Alcohol Clin Exp Res. 1996;20:67A-71A.
38. Reddy MA, Shukla SD. Nuclear activation and translocation of mitogen-activated protein kinases modulated by ethanol in embryonic liver cells. Biochim Biophys Acta. 2000;1497:271-278.
39. Zeldin G, Yang SQ, Yin M, et al. Alcohol and cytokine-inducible transcription factors. Alcohol Clin Exp Res. 1996;20:1639-1645.
40. Chen J, Bao H, Sawyer S, et al. Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem Biophys Res Commun. 1997;239:666-669.
41. Roivainen R, Hundle B, Messing OR. Ethanol enhances growth factor activation of mitogen-activated protein kinases by a protein kinase C-dependent mechanism. Proc Natl Acad Sci USA. 1995;92:1891-1895.
42. Tombes RM, Auer KL, Mikkelsen R, et al. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J. 1998;330:1451-1460.
43. Clavel F, Benhamou E, Auquier A, et al. Coffee, alcohol, smoking and cancer of the pancreas: a case-control study. Int J Cancer. 1989;43:17-22.
44. Farrow DC, Davis S. Diet and the risk of pancreatic cancer in men. Am J Epidemiol. 1990;132:423-431.
45. Ghadirian P, Simard A, Baillargeon J. Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. Cancer. 1991;67:2664-2670.
46. Malats N, Porta M, Corominas JM, et al. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras. I Project Investigators. Int J Cancer. 1997;70:661-667.
47. Talamini G, Bassi C, Falconi M, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci. 1999;44:1303-1311.
48. Silverman DT, Brown LM, Hoover RN, et al. Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res. 1995;55:4899-4905.
49. Rosenberg D, Groussin L, Jullian E, et al. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann N Y Acad Sci. 2002;968:65-74.
50. Yamamoto KK, Gonzalez GA, Wiggs BH, et al. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature. 1988;334:494-498.
51. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 1989;59:675-680.
52. Meyer TE, Habener JF. Cyclic adenosine 3,5-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr Rev. 1993;14:269-290.
53. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599-609.
54. Erhardt P, Troppmair J, Rapp UR, et al. Differential regulation of Raf-1 and B-raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol. 1995;15:5524-5530.
55. Englaro W, Rezzonico R, Durand-Clement M, et al. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem. 1995;270:24315-24320.
56. Vaillancourt RR, Gardner AM, Johnson GL. B-raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP. Mol Cell Biol. 1994;14:6522-6530.
57. Vossler MR, Yao H, York RD, et al. cAMP activates MAP kinase and Elk-1 through a B-raf- and Rap 1-dependent pathway. Cell. 1997;89:73-82.
58. Wan Y, Huang XY. Analysis of the Gs/mitogen-activated protein kinase pathway in mutant S49 cells. J Biol Chem. 1998;273:14533-14537.
59. Graves LM, Bornfeldt KE, Raines EW, et al. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA. 1993;90:10300-10304.
60. Dugan LL, Kim JS, Zhang Y, et al. Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem. 1999;274:25842-25848.
61. Wu J, Dent P, Jelinek T, et al. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3,5-monophosphate. Science. 1993;262:1065-1069.
62. Vossler MR, Yao H, York RD, et al. cAMP activates MAP kinase and Elk-1 through a B-raf and Rap1-dependent pathway. Cell. 1997;89:73-82.
63. Maizels ET, Cottom J, Jones JCR, et al. Follicle stimulating hormone (FSH) activates the p38 mitogen-activated protein kinase pathway, inducing small heat shock protein phosphorylation and cell rounding in immature rat ovarian granulosa cells. Endocrinology. 1998;139:3353-3356.
64. Qui W, Zhuang S, von Lintig FC, et al. Cell type-specific regulation of B-raf kinase by cAMP and 14-3-3 proteins. J Biol Chem. 2000;275:31921-31929.
65. Gonzalez-Robayna IJ, Falender AE, Ochsner S, et al. Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for A-kinase independent signaling in granulosa cells. Mol Endocrinol. 2000;14:1283-1300.
66. Aroor AR, Shukla SD. MAP kinase signaling in diverse effects of ethanol. Life Sci. 2004;74:2339-2364.
67. Aroor AR, Custer GW, Weng YI, et al. Phosphatidylethanol mimics ethanol modulation of p42/44 mitogen-activated protein kinase signalling in hepatocytes. Alcohol Alcohol. 2002;37:534-539.
68. Smith TL, Navratilova E. The effect of ethanol exposure on mitogen-activated protein kinase activity and expression in cultured rat astrocytes. Neurosci Lett. 2003;341:91-94.
69. McKillop IH, Vyas N, Schmidt CM, et al. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma. Hepatology. 1999;29:412-420.
70. Weng YI, Shukla SD. Ethanol alters angiotensin II stimulated mitogen-activated protein kinase in hepatocytes: agonist selectivity and ethanol metabolic independence. Eur J Pharmacol. 2000;398:323-331.